SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

~~October 29~~August 5, ~~2003~~ 2004

Date of Report (Date of
earliest event reported)

ProCyte Corporation

(Exact Name of Registrant as Specified in Charter)

Washington	0-18044	91-1307460
Washington (State or Other Jurisdiction of Incorporation)	0-18044 (Commission File No.)		91-1307460 (IRS Employer Identification No.)
(State or Other Jurisdiction of Incorporation)	(Commission File No.)	(IRS Employer Identification No.)
8511 154th Avenue, NE, Building A, Redmond, WA (Address of principal executive offices)				98052-3557 (Zip Code)
8511 154th Avenue, NE, Building A, Redmond, WA		98052-3557
(425) 869-1239 (Registrant’s telephone number, including area code)
(Address of principal executive offices)		(Zip Code)
(425) 869-1239
(Registrant’s telephone number, including area code)

Item 7.	Financial Statements, Pro Forma Financial Information and Exhibits
(c)	Exhibits
	99.1	Press Release of ProCyte Corporation, dated October 29, 2003
Item 9.	Regulation FD Disclosure

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

The information included in this section is intended to be included in “Item 12. Disclosure of Results of Operations and Financial Condition” and is included under this Item 9 in accordance with SEC Release No. 33-8216.(c) Exhibits

On99.1 Press Release ~~October~~of ~~29, 2003,~~ ProCyte Corporation, ~~issued~~dated ~~a press release announcing its third quarter earnings for the fiscal quarter ended September 30~~August 5, ~~2003. A copy of the press release is attached hereto as Exhibit 99.1.~~2004

2Item 9. Regulation FD Disclosure

~~SIGNATURE~~The information included in this section is intended to be included in “Item 12. Disclosure of Results of Operations and Financial Condition” and is included under this Item 9 in accordance with SEC Release No. 33-8216.

~~Pursuant~~On toAugust 5, ~~the~~2004, ~~requirements~~ProCyte ofCorporation ~~the~~issued ~~Securities~~a press release ~~Exchange~~announcing ~~Act~~its ofearnings ~~1934,~~for the ~~registrant~~fiscal ~~has~~quarter ~~duly~~ended ~~caused~~June 30, ~~this~~2004. A ~~report~~copy toof bethe ~~signed on~~press ~~its~~release ~~behalf~~is byattached hereto ~~the~~as ~~undersigned~~Exhibit ~~hereunto duly authorized~~99.1.

	ProCyte Corporation
Dated: October 29, 2003	By	/s/ Robert W. Benson
		Robert W. Benson
		Chief Financial Officer

3SIGNATURE

~~EXHIBIT~~Pursuant ~~INDEX~~to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit No.		Description
	ProCyte Corporation
99.1		Press Release dated October 29, 2003
Dated: August 9, 2004	By	/s/ Robert W. Benson
		Robert W. Benson
		Chief Financial Officer

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press release dated August 5, 2004

Filing Compare · PROCYTE CORP /WA/